Products - Pulmonary fibrosis | Topic | NICE

Showing 3 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
4 March 2026
Nintedanib for treating fibrosing interstitial lung disease in people aged 6 to 17 [ID6194]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Nerandomilast for treating idiopathic pulmonary fibrosis or progressive pulmonary fibrosis ID6446
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC